pembrolizumab,lenvatinib
merck,eisai
['key,note,b61', 'pembro', 'keynoteb61', 'lenva', 'renal,(-adrenal)']
first-line lenvatinib + pembrolizumab treatment across non-clear cell #renalcellcarcinomas: results of the phase 2 #keynoteb61 study. presented by . #asco23 coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology